Abhishek Nag

AstraZeneca (United Kingdom) — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

26h-index4.3kcitations62works9.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Genetic Associations and Epidemiology(20), Glaucoma and retinal disorders(17), Retinal Diseases and Treatments(14), Genomics and Rare Diseases(10), Corneal surgery and disorders(9)

Publications60 total

Identification of plasma proteomic markers underlying polygenic risk of type 2 diabetes and related comorbidities
Nature Communications·2025· 15 citedOpen Access
Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases
Nature Communications·2025· 7 citedOpen Access
Comparative analysis of the Mexico City Prospective Study and the UK Biobank identifies ancestry-specific effects on clonal hematopoiesis
Nature Genetics·2025· 8 citedOpen Access
Genetic architecture of telomere length in 462,666 UK Biobank whole-genome sequences
Nature Genetics·2024· 38 citedOpen Access
Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases
2024· 4 citedOpen Access
Identification of plasma proteomic markers underlying polygenic risk of type 2 diabetes and related comorbidities
2024· 1 citedOpen Access
Comparative analysis of 136,401 Admixed Americans and 419,228 Europeans reveals ancestry-specific genetic determinants of clonal haematopoiesis
2024· 2 citedOpen Access
Author Correction: Genotyping, sequencing and analysis of 140,000 adults from Mexico City
Nature·2024· 1 citedOpen Access
Ancestry-Specific Genetic Determinants of Clonal Haematopoiesis: A Comparative Analysis of 136,401 Admixed Americans and 419,228 Europeans
Blood·2023· 2 cited
Genotyping, sequencing and analysis of 140,000 adults from Mexico City
Nature·2023· 84 citedOpen Access
Rare variant associations with plasma protein levels in the UK Biobank
Nature·2023· 158 citedOpen Access
Genetic architecture of telomere length in 462,675 UK Biobank whole-genome sequences
2023· 6 citedOpen Access
Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH
Diabetologia·2023· 12 citedOpen Access
Effects of protein-coding variants on blood metabolite measurements and clinical biomarkers in the UK Biobank
The American Journal of Human Genetics·2023· 23 citedOpen Access
Human genetics uncovers <i>MAP3K15</i> as an obesity-independent therapeutic target for diabetes
Science Advances·2022· 32 citedOpen Access
Genotyping, sequencing and analysis of 140,000 adults from the Mexico City Prospective Study
2022· 15 citedOpen Access
Gene-SCOUT: identifying genes with similar continuous trait fingerprints from phenome-wide association analyses
Nucleic Acids Research·2022· 6 citedOpen Access
Assessing the contribution of rare-to-common protein-coding variants to circulating metabolic biomarker levels via 412,394 UK Biobank exome sequences
2021· 13 citedOpen Access
Human genetic evidence supports MAP3K15 inhibition as a therapeutic strategy for diabetes
2021· 7 citedOpen Access
Rare variant contribution to human disease in 281,104 UK Biobank exomes
Nature·2021· 552 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Slavé Petrovski(21), Pirro G. Hysi(19), Christopher J. Hammond(18), Quanli Wang(16), Ryan S. Dhindsa(15), Katherine R. Smith(15), Dimitrios Vitsios(14), Keren Carss(12), Andrew R. Harper(12), André G. Uitterlinden(12), René Höhn(11), Cornelia M. van Duijn(11), Sebastian Wasilewski(10), Tien Yin Wong(10), Caroline C. W. Klaver(10), Dirk S. Paul(9), Stuart MacGregor(9), Alex W. Hewitt(9), Fernando Rivadeneira(9), Najaf Amin(9)